9th Annual EU Medical Device & Diagnostic Reimbursement & Market Access Conference 2020
Due to the current situation, the 3-day conference took place only virtually from June 16 to 18, 2020.
The objective of this year’s EU Medical Device & Diagnostic Reimbursement & Market Access Conference was to shed light onto coverage opportunities for digital health products and to analyze the impact of MDR on clinical and follow-on impact on market access. Continuously optimizing strategies to meet various payer expectations and successfully achieve reimbursement was also one of the key points on the agenda.
From our team, Francesca Boggio virtually attended the conference. If you would like to discuss with her and connect virtually, simply send her an email to email@example.com.
To find out more about the conference, please visit the official website for the 2020 event here.
Are you interested in the topic? Then you might find the following articles, interviews and papers helpful:
- Reimbursement Pathways for New Diabetes Technologies in Europe: Top-Down Versus Bottom-Up
(August 2018, Peer-reviewed article published in the Journal of Diabetes Science and Technology)
- Early Market Access assessment for diagnostics in personalized medicine
(Presentation held at the World Pharma Pricing & Market Access Congress 2017)
- Access & reimbursement to reward innovation in digital "BTP" solutions
(November 2017, Poster/Report presented at ISPOR)